Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.23
+0.73 (13.27%)
At close: Mar 6, 2026, 4:00 PM EST
6.20
-0.03 (-0.48%)
After-hours: Mar 6, 2026, 7:25 PM EST
Silence Therapeutics Employees
Silence Therapeutics had 116 employees as of December 31, 2024. The number of employees increased by 7 or 6.42% compared to the previous year.
Employees
116
Change (1Y)
7
Growth (1Y)
6.42%
Revenue / Employee
$4,819
Profits / Employee
-$763,897
Market Cap
294.27M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| AC Immune | 172 |
| Coherus Oncology | 158 |
| Abeona Therapeutics | 136 |
| OmniAb | 114 |
| Keros Therapeutics | 82 |
| Enlivex | 71 |
| ALX Oncology Holdings | 44 |
SLN News
- 2 days ago - Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 2 months ago - Silence Therapeutics Announces Leadership Changes - Business Wire
- 3 months ago - Silence Therapeutics: Divesiran Targets High-Burden PV - Seeking Alpha
- 4 months ago - Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference - Business Wire
- 4 months ago - Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 4 months ago - Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV) - Business Wire
- 6 months ago - Silence Therapeutics Plc (SLN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 months ago - Silence Therapeutics to Participate in September Investor Conferences - Business Wire